Sunrest Lifescience Limited (NSE:SUNREST)
36.30
+0.20 (0.55%)
Apr 29, 2026, 3:03 PM IST
Sunrest Lifescience Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Cash & Equivalents | 9.95 | 17.38 | 2.9 | 4.5 | 4.8 | 3.73 | Upgrade
|
| Cash & Short-Term Investments | 9.95 | 17.38 | 2.9 | 4.5 | 4.8 | 3.73 | Upgrade
|
| Cash Growth | 226.27% | 500.45% | -35.65% | -6.27% | 28.65% | 8.62% | Upgrade
|
| Accounts Receivable | 293.33 | 363.65 | 149.98 | 108.57 | 93.47 | 74.02 | Upgrade
|
| Other Receivables | - | 3.43 | - | - | - | - | Upgrade
|
| Receivables | 372.18 | 367.08 | 152.18 | 108.57 | 94.97 | 74.02 | Upgrade
|
| Inventory | 112.93 | 96.24 | 50.51 | 39.41 | 22.95 | 15.22 | Upgrade
|
| Prepaid Expenses | - | 0.18 | 0.14 | 0.1 | - | - | Upgrade
|
| Other Current Assets | 1.27 | 55.03 | 42.59 | 10.46 | 2.77 | 0.28 | Upgrade
|
| Total Current Assets | 496.33 | 535.92 | 248.31 | 163.04 | 125.48 | 93.25 | Upgrade
|
| Property, Plant & Equipment | 82.01 | 43.56 | 2.54 | 3.51 | 4.67 | 1.49 | Upgrade
|
| Long-Term Investments | - | - | 0.17 | 0.17 | - | - | Upgrade
|
| Other Intangible Assets | 0.07 | 0.08 | 0.07 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 2.64 | 4.06 | 0.22 | 0.15 | 0.05 | 0.08 | Upgrade
|
| Other Long-Term Assets | 16.41 | 2.88 | 0.25 | 0.26 | -0 | -0 | Upgrade
|
| Total Assets | 597.46 | 586.5 | 251.56 | 167.12 | 130.2 | 94.82 | Upgrade
|
| Accounts Payable | 152.26 | 229.34 | 37.96 | 86.18 | 79.33 | 64.11 | Upgrade
|
| Accrued Expenses | 61.79 | 7.02 | 3.79 | 6.15 | 4.03 | 3.96 | Upgrade
|
| Short-Term Debt | 51.91 | 62.51 | 25.59 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.67 | 1.39 | 1.46 | 1.46 | 0.39 | Upgrade
|
| Current Income Taxes Payable | - | 9.94 | 3.74 | 7.1 | 2.72 | 0.65 | Upgrade
|
| Other Current Liabilities | - | - | 2.62 | 15.12 | 1.01 | - | Upgrade
|
| Total Current Liabilities | 265.96 | 309.47 | 75.08 | 116.01 | 88.55 | 69.1 | Upgrade
|
| Long-Term Debt | 104.97 | 57.33 | 34.62 | 19.97 | 30.92 | 22.76 | Upgrade
|
| Other Long-Term Liabilities | 3.7 | 3.4 | - | -0 | -0 | -0 | Upgrade
|
| Total Liabilities | 374.63 | 370.2 | 109.7 | 135.98 | 119.48 | 91.87 | Upgrade
|
| Common Stock | 21.46 | 42.91 | 42.91 | 30 | 0.1 | 0.1 | Upgrade
|
| Additional Paid-In Capital | - | 95.55 | - | - | - | - | Upgrade
|
| Retained Earnings | - | 23.45 | 98.94 | 1.14 | 10.62 | 2.85 | Upgrade
|
| Comprehensive Income & Other | 145.02 | 1.2 | - | - | - | - | Upgrade
|
| Total Common Equity | 166.47 | 163.11 | 141.85 | 31.14 | 10.72 | 2.95 | Upgrade
|
| Minority Interest | 56.36 | 53.19 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 222.83 | 216.3 | 141.85 | 31.14 | 10.72 | 2.95 | Upgrade
|
| Total Liabilities & Equity | 597.46 | 586.5 | 251.56 | 167.12 | 130.2 | 94.82 | Upgrade
|
| Total Debt | 156.88 | 120.5 | 61.6 | 21.43 | 32.38 | 23.15 | Upgrade
|
| Net Cash (Debt) | -146.93 | -103.12 | -58.7 | -16.93 | -27.58 | -19.42 | Upgrade
|
| Net Cash Per Share | -34.24 | -24.03 | -17.67 | -5.64 | -9.19 | -6.47 | Upgrade
|
| Filing Date Shares Outstanding | 4.29 | 4.29 | 4.29 | 3 | 3 | 3 | Upgrade
|
| Total Common Shares Outstanding | 4.29 | 4.29 | 4.29 | 3 | 3 | 3 | Upgrade
|
| Working Capital | 230.37 | 226.45 | 173.23 | 47.03 | 36.93 | 24.15 | Upgrade
|
| Book Value Per Share | 38.79 | 38.01 | 33.06 | 10.38 | 3.57 | 0.98 | Upgrade
|
| Tangible Book Value | 166.41 | 163.03 | 141.79 | 31.14 | 10.72 | 2.95 | Upgrade
|
| Tangible Book Value Per Share | 38.78 | 37.99 | 33.04 | 10.38 | 3.57 | 0.98 | Upgrade
|
| Buildings | - | 15.08 | - | - | - | - | Upgrade
|
| Machinery | - | 35.94 | 5.25 | 5.27 | 5.13 | 1.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.